A detailed history of Manning & Napier Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 150,126 shares of VRTX stock, worth $69.3 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
150,126
Previous 155,761 3.62%
Holding current value
$69.3 Million
Previous $72.4 Billion 16.55%
% of portfolio
0.69%
Previous 0.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$396.64 - $516.74 $2.24 Million - $2.91 Million
-5,635 Reduced 3.62%
150,126 $60.5 Billion
Q3 2024

Oct 17, 2024

SELL
$460.0 - $505.78 $1.18 Million - $1.3 Million
-2,571 Reduced 1.62%
155,761 $72.4 Billion
Q2 2024

Jul 11, 2024

BUY
$392.81 - $485.53 $62.2 Million - $76.9 Million
158,332 New
158,332 $74.2 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Manning & Napier Advisors LLC Portfolio

Follow Manning & Napier Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Advisors LLC with notifications on news.